Dr. Harvey Risch: Therapeutics Highly Effective in Early COVID Treatment

In the interview, Dr. Risch criticized the U.S. Food and Drug Administration (FDA) for warning against hydroxychloroquine and chloroquine use to treat COVID-19 and revoking the emergency use authorization (EUA) for hydroxychloroquine and chloroquine.

"I'm looking at clinicians who have now treated more than 150,000 patients, with fewer than 2 dozen deaths, with #hydroxychloroquine."

Yale epidemiologist Dr. Harvey Risch on the efficacy of hydroxychloroquine, #Ivermectin & other therapeutics.